Volume | 2 583 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 2,93 | Bas Haut |
|||||
Minimum Bas | 2,86 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Acasti Pharma Inc | ACST | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
2,86 | 2,86 | 2,93 | 2,9285 | 2,90 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
60 | 2 583 | US$ 2,87 | US$ 7 418 | - | 1,72 - 3,84 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
00:17:29 | 5 | US$ 3,03 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
5,45M | 9,40M | - | 0 | -42,43M | -4,51 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Acasti Pharma
Date | Heure | Source | Titre |
---|---|---|---|
12/2/2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
12/2/2024 | 13:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
08/1/2024 | 14:00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
08/1/2024 | 13:30 | Edgar (US Regulatory) | Form 8-K - Current report |
20/12/2023 | 22:08 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
20/12/2023 | 22:08 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
20/12/2023 | 22:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
15/12/2023 | 13:30 | Edgar (US Regulatory) | Form 8-K - Current report |
13/11/2023 | 13:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
23/10/2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
16/10/2023 | 22:31 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
11/10/2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Acasti Pharma
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Acasti Pharma Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 3,17 | 3,19 | 2,81 | 2,91 | 10 475 | -0,2415 | -7,62% |
1 mois | 3,42 | 3,50 | 2,81 | 3,32 | 17 960 | -0,4915 | -14,37% |
3 mois | 2,47 | 3,59 | 2,25 | 3,22 | 27 508 | 0,4585 | 18,56% |
6 mois | 2,37 | 3,59 | 1,98 | 2,90 | 24 357 | 0,5585 | 23,57% |
1 an | 2,88 | 3,84 | 1,72 | 2,90 | 46 950 | 0,0485 | 1,68% |
3 ans | 2,8806 | 17,6352 | 1,72 | 3,91 | 1 579 970 | 0,0479 | 1,66% |
5 ans | 5,46 | 18,48 | 1,026 | 4,18 | 4 909 158 | -2,53 | -46,36% |